Mastocytosis: reactive or neoplastic?

PubWeight™: 0.78‹?›

🔗 View Article (PMC 499999)

Published in J Clin Pathol on June 01, 1997

Authors

S M Kröber1, H P Horny, P Ruck, U Kämmerer, A Geiselhart, R Handgretinger, H Griesser, D M Menke, E Kaiserling

Author Affiliations

1: Department of Pathology, Eberhard-Karls University, Tübingen, Germany.

Articles by these authors

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (1995) 16.19

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature (1998) 7.55

Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science (1995) 5.27

Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87

Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med (1999) 2.89

Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet (1999) 2.35

Desmoplastic fibroma of the bone. A report of two patients, review of the literature, and therapeutic implications. Cancer (1996) 2.34

Pure red cell aplasia. Br J Haematol (2000) 1.91

Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol (1993) 1.83

Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell (1996) 1.78

Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haematol (1990) 1.77

Subcutaneous T-cell lymphoma. Report of two additional cases and further observations. Arch Dermatol (1993) 1.73

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy (2006) 1.64

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant (2001) 1.50

Squamous cell carcinoma of the gastric stump. A case report and review of the literature. Am J Surg Pathol (1989) 1.49

In situ immunophenotyping of lymphocytes in human bone marrow: an immunohistochemical study. Br J Haematol (1989) 1.49

Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. Cancer Res (1991) 1.48

Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago. Bone Marrow Transplant (2004) 1.48

Nephron sparing surgery for synchronous bilateral nephroblastoma involving the renal hilus. J Urol (2011) 1.47

Mast cell sarcoma of the larynx. J Clin Pathol (1986) 1.41

Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Mod Pathol (1994) 1.40

Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprinting. Transplantation (2001) 1.39

Intradecidual T lymphocytes lack immunohistochemically detectable T-cell receptors. Am J Reprod Immunol (1990) 1.39

Bone marrow findings in systemic mastocytosis. Hum Pathol (1985) 1.39

Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma. Br J Cancer (2007) 1.38

Is the "wick method" appropriate to determine the protein osmotic pressure of interstitial fluid? Lymphology (1996) 1.35

Renal involvement in myeloproliferative and lymphoproliferative disorders. A study of autopsy cases. Gen Diagn Pathol (1997) 1.35

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm (2000) 1.33

Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood (2000) 1.30

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia (2010) 1.29

Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology (1979) 1.28

Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol (1998) 1.28

Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene (1995) 1.27

Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J Cutan Pathol (2000) 1.27

Langerhans cells and interdigitating reticulum cells in the thymus-dependent region in human dermatopathic lymphadenitis. Virchows Arch B Cell Pathol (1977) 1.27

Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol (1995) 1.26

Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations. Blood (1993) 1.26

Involvement of the larynx by hemopoietic neoplasms. An investigation of autopsy cases and review of the literature. Pathol Res Pract (1995) 1.25

[Interdigitating reticulum cell in the human lymph node. A specific cell of the thymus dependent region (author's transl)]. Virchows Arch B Cell Pathol (1974) 1.25

Experimental Listeria cystitis. II. Further evidence of the epithelial phase in experimental Listeria infection. An electron microscopic study. Virchows Arch B Cell Pathol (1973) 1.21

Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol (2002) 1.20

Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res (2001) 1.17

Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders. J Clin Invest (1986) 1.17

Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma (2000) 1.16

Incidence and pattern of liver involvement in haematological malignancies. Pathol Res Pract (1998) 1.16

Use of monoclonal antibody KP1 for identifying normal and neoplastic human mast cells. J Clin Pathol (1990) 1.15

Hypoplastic coronary arteries and high takeoff position of the right coronary ostium. A fatal combination of congenital coronary artery anomalies in an amateur athlete. Chest (1985) 1.14

Sequence and organization of the human T cell delta chain gene. Eur J Immunol (1988) 1.13

Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer Suppl (1975) 1.13

Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am J Pathol (1991) 1.12

Ultrastructural localization of HMB-45 binding sites. J Cutan Pathol (1991) 1.12

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia (2002) 1.11

Massive cavernous lymphangioma of the breast and thoracic wall: case report and literature review. Lymphology (2006) 1.11

Primary lymph node plasmacytomas (plasmacytic lymphomas). Am J Clin Pathol (2001) 1.11

Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol (1979) 1.09

Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line. Eur J Cancer (1995) 1.09

Congenital epulis and granular cell tumor: a histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 1.08

Purification of human natural killer cells using a clinical-scale immunomagnetic method. Cytotherapy (2003) 1.08

Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res (1990) 1.08

Repertoire of the human T cell gamma genes: high frequency of nonfunctional transcripts in thymus and mature T cells. Eur J Immunol (1987) 1.07

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant (1998) 1.06

Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer (1997) 1.06

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia. Mol Pathol (2000) 1.05

Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J Infect Dis (1999) 1.05

Interdigitating reticulum cells in the human thymus. Cell Tissue Res (1974) 1.05

Small epithelial cells in human liver cirrhosis exhibit features of hepatic stem-like cells: immunohistochemical, electron microscopic and immunoelectron microscopic findings. Histopathology (2003) 1.05

MIC-1 (a multifunctional modulator of dendritic cell phenotype and function) is produced by decidual stromal cells and trophoblasts. Hum Reprod (2011) 1.04

Tissue mast cells in health and disease. Pathol Res Pract (1985) 1.04

Clonal rearrangements of T-cell receptor and immunoglobulin genes and immunophenotypic antigen expression in different subclasses of Hodgkin's disease. Int J Cancer (1987) 1.04

Small epithelial cells in extrahepatic biliary atresia: electron microscopic and immunoelectron microscopic findings suggest a close relationship to liver progenitor cells. Histopathology (1999) 1.04

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer Lett (2003) 1.04

Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells. Cancer (1993) 1.04

Letter: T-associated plasma-cells. Lancet (1975) 1.03

A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem (2001) 1.03

Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology (1997) 1.02

Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med (1992) 1.02

Detection of elevated caspase activation and early apoptosis in liver diseases. Eur J Cell Biol (2001) 1.02

Frequent expression of haemopoietic and non-haemopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology (1992) 1.02

Intravascular lymphomatosis. A report of ten patients with central nervous system involvement and a review of the disease process. Adv Exp Med Biol (1999) 1.02

Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study. Br J Haematol (1988) 1.01

A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy (2007) 1.01

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother (1999) 1.00